{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:08:54Z","timestamp":1789841334175,"version":"4.0.1"},"reference-count":290,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.prp.2023.154375","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:19:29Z","timestamp":1676391569000},"page":"154375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["The role of miRNAs in liver diseases: Potential therapeutic and clinical applications"],"prefix":"10.1016","volume":"243","author":[{"given":"Ahmed S.","family":"Doghish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Elazazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Elesawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem K.","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Midan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Aliaa M.","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.prp.2023.154375_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"MacFarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"10.1016\/j.prp.2023.154375_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.134","article-title":"miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: a spotlight on signaling pathways interplay\u2014A review","volume":"214","author":"Elrebehy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154375_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154053","article-title":"A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: a focus on signaling pathways interplay","author":"Doghish","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154375_bib5","article-title":"Classical and noncanonical functions of miRNAs in cancers","author":"Dragomir","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.prp.2023.154375_bib6","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","author":"Doghish","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154375_bib7","article-title":"Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: a comprehensive review","author":"Ismail","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"7795","key":"10.1016\/j.prp.2023.154375_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2023.154375_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.prp.2023.154375_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2023.154375_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib12","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.154375_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154375_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.prp.2023.154375_bib17","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications\u2013a review","author":"Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154375_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"Plos One"},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in adult Egyptian male patients with metabolic syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.154375_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes, Metab. Syndr. Obes.: Targets Ther."},{"key":"10.1016\/j.prp.2023.154375_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154222","article-title":"The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance-a focus on signaling pathways interplay","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154375_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154363","article-title":"miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013 an emphasis on the interaction of signaling pathways","volume":"243","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154375_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154316","article-title":"miRNAs role in bladder cancer pathogenesis and targeted therapy: signaling pathways interplay-a review","author":"El-Mahdy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154375_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153886","article-title":"miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers","author":"El-Mahdy","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"26","key":"10.1016\/j.prp.2023.154375_bib27","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib28","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.27250","article-title":"MicroRNAs play a role in spontaneous recovery from acute liver failure","volume":"60","author":"John","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/ijms18040803","article-title":"Drug induced liver injury: can biomarkers assist RUCAM in causality assessment?","volume":"18","author":"Teschke","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.prp.2023.154375_bib30","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib31","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug\u2010induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"Cmaj"},{"key":"10.1016\/j.prp.2023.154375_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fphar.2016.00267","article-title":"Biomarkers in DILI: one more step forward","volume":"7","author":"Robles-D\u00edaz","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gutjnl-2016-311861","article-title":"MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6\u2013p47phox\u2013oxidative stress pathway in neutrophils","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajpath.2015.10.003","article-title":"Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma","volume":"186","author":"Bhattacharya","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/joim.12099","article-title":"miR\u2010223: infection, inflammation and cancer","volume":"274","author":"Haneklaus","year":"2013","journal-title":"J. Intern. Med."},{"issue":"11","key":"10.1016\/j.prp.2023.154375_bib37","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-008-0629-8","article-title":"Association of MicroRNA-223 expression with hepatic ischemia\/reperfusion injury in mice","volume":"54","author":"Yu","year":"2009","journal-title":"Dig. Dis. Sci."},{"issue":"15","key":"10.1016\/j.prp.2023.154375_bib38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1042\/CS20170218","article-title":"miR-223 represents a biomarker in acute and chronic liver injury","volume":"131","author":"Schueller","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.prp.2023.154375_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860661","article-title":"miR-223 as a regulator and therapeutic target in liver diseases","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib40","article-title":"miR-150 deficiency protects against FAS-induced acute liver injury in mice through regulation of AKT","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib41","first-page":"1","article-title":"MicroRNA-125b-5p mimic inhibits acute liver failure","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.154375_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.intimp.2016.09.011","article-title":"Fine-tuning the expression of microRNA-155 controls acetaminophen-induced liver inflammation","volume":"40","author":"Yuan","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/toxsci\/kfr130","article-title":"Involvement of microRNAs in dioxin-induced liver damage in the mouse","volume":"122","author":"Yoshioka","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"14","key":"10.1016\/j.prp.2023.154375_bib44","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1042\/CS20160216","article-title":"Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury","volume":"130","author":"Roy","year":"2016","journal-title":"Clin. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib45","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jhep.2017.06.007","article-title":"miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib","volume":"67","author":"Roy","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2023.154375_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fphar.2015.00236","article-title":"Integrated expression profiles of mRNA and microRNA in the liver of Fructus Meliae Toosendan water extract injured mice","volume":"6","author":"Zheng","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037395","article-title":"A panel of serum microRNAs as specific biomarkers for diagnosis of compound-and herb-induced liver injury in rats","volume":"7","author":"Su","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/liv.13312","article-title":"Profiles of mi RNA s in serum in severe acute drug induced liver injury and their prognostic significance","volume":"37","author":"Russo","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.prp.2023.154375_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117401","article-title":"Pretreatment of exosomes derived from hUCMSCs with TNF-\u03b1 ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage","volume":"246","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib50","article-title":"Circulating miR-122 and miR-192 as specific and sensitive biomarkers for drug-induced liver injury with acetaminophen in rats","volume":"14","author":"Jarsiah","year":"2019","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"issue":"9","key":"10.1016\/j.prp.2023.154375_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0153-7","article-title":"Role of miR-223 in the pathophysiology of liver diseases","volume":"50","author":"Ye","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5152\/tjg.2019.18159","article-title":"Up-regulation of miR-155 contributes to TNF-mediated hepatocyte apoptosis in acute liver failure","volume":"30","author":"Zhang","year":"2019","journal-title":"Turk. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/hep.29833","article-title":"Expression of microRNA\u2010155 in inflammatory cells modulates liver injury","volume":"68","author":"Blaya","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jb\/mvaa056","article-title":"Mangiferin alleviates endoplasmic reticulum stress in acute liver injury by regulating the miR-20a\/miR-101a-Nrf2 axis","volume":"168","author":"Li","year":"2020","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-1550-0","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p","volume":"11","author":"Shao","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15760-4","article-title":"Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip","volume":"7","author":"Saikia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154375_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120751","article-title":"Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: focusing on the role of C1q\/tumor necrosis factor-related protein-3 and ATP citrate lyase","volume":"305","author":"Elseweidy","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154375_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15221","article-title":"Management of alcohol\u2010related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines","author":"Louvet","year":"2022","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.prp.2023.154375_bib59","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1021\/acs.analchem.7b01144","article-title":"Visualizing the conversion process of alcohol-induced fatty liver to steatohepatitis in vivo with a fluorescent nanoprobe","volume":"89","author":"Yang","year":"2017","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib60","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jcp.26938","article-title":"MicroRNAs in alcoholic liver disease: Recent advances and future applications","volume":"234","author":"Xu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib61","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib62","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.gastro.2017.09.022","article-title":"MicroRNA 122, regulated by GRLH2, protects livers of mice and patients from ethanol-induced liver disease","volume":"154","author":"Satishchandran","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib63","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jcmm.12223","article-title":"The functional role of micro RNA s in alcoholic liver injury","volume":"18","author":"McDaniel","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib65","first-page":"250","article-title":"MicroRNA-200a induces apoptosis by targeting ZEB2 in alcoholic liver disease","volume":"17","author":"Zhao","year":"2018","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.prp.2023.154375_bib66","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00109-015-1282-2","article-title":"MiR-26a enhances autophagy to protect against ethanol-induced acute liver injury","volume":"93","author":"Han","year":"2015","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib67","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/gutjnl-2017-315123","article-title":"Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression","volume":"68","author":"Heo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.prp.2023.154375_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114582","article-title":"A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease","volume":"188","author":"Luo","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.prp.2023.154375_bib69","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3390\/ijms20112712","article-title":"Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease","volume":"20","author":"Kong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"40","key":"10.1016\/j.prp.2023.154375_bib70","doi-asserted-by":"crossref","first-page":"27526","DOI":"10.1074\/jbc.M114.602383","article-title":"Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury","volume":"289","author":"Francis","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.150","article-title":"LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer","volume":"6","author":"Liu","year":"2015","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib72","article-title":"Self-assembly of peptides into hydrogel","volume":"2","author":"Sun","year":"2016","journal-title":"J. Org. Inorg. Chem."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jceh.2013.09.001","article-title":"MicroRNAs in liver disease: bench to bedside","volume":"3","author":"Shah","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib74","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/gutjnl-2016-312966","article-title":"A small RNA in neutrophils protects against acute-on-chronic alcoholic liver injury","volume":"66","author":"Wang","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.prp.2023.154375_bib75","series-title":"MicroRNAs in alcoholic liver disease, Seminars in liver disease","first-page":"036","author":"Szabo","year":"2015"},{"key":"10.1016\/j.prp.2023.154375_bib76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphar.2018.00275","article-title":"miR-203 inhibits alcohol-induced hepatic steatosis by targeting lipin1","volume":"9","author":"Cheng","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"38","key":"10.1016\/j.prp.2023.154375_bib77","doi-asserted-by":"crossref","first-page":"64294","DOI":"10.18632\/oncotarget.19729","article-title":"MiR-30e-UCP2 pathway regulates alcoholic hepatitis progress by influencing ATP and hydrogen peroxide expression","volume":"8","author":"Jin","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib78","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/acer.13116","article-title":"Processing of miR17\u201392 cluster in hepatic stellate cells promotes hepatic fibrogenesis during alcohol\u2010induced injury","volume":"40","author":"Brandon\u2010Warner","year":"2016","journal-title":"Alcohol.: Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12386","article-title":"Melatonin ameliorates alcohol\u2010induced bile acid synthesis by enhancing miR\u2010497 expression","volume":"62","author":"Kim","year":"2017","journal-title":"J. Pineal Res."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib80","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ajpath.2015.01.030","article-title":"miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1\u2013Lipin-1 signaling","volume":"185","author":"Yin","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/acer.12209","article-title":"MiR\u2010214 promotes the alcohol\u2010induced oxidative stress via down\u2010regulation of glutathione reductase and cytochrome P450 oxidoreductase in liver cells","volume":"38","author":"Dong","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.prp.2023.154375_bib82","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/498232","article-title":"MicroRNA signature in alcoholic liver disease","author":"Bala","year":"2012","journal-title":"Int. J. Hepatol."},{"issue":"12","key":"10.1016\/j.prp.2023.154375_bib83","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/v12121440","article-title":"miRNAs as potential biomarkers for viral hepatitis B and C","volume":"12","author":"Loureiro","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib84","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib85","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jhep.2012.05.016","article-title":"Genomics and HCV infection: progression of fibrosis and treatment response","volume":"57","author":"Estrabaud","year":"2012","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.prp.2023.154375_bib86","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S2468-1253(19)30190-6","article-title":"Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure","volume":"4","author":"Asselah","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2023.154375_bib87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13673","article-title":"Treatment of hepatitis C virus infection with direct\u2010acting antiviral agents: 100% cure?","volume":"38","author":"Asselah","year":"2018","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep34935","article-title":"MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C","volume":"6","author":"Appourchaux","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib89","first-page":"882","article-title":"Serum microRNA\u2011125a\u20115p as a potential biomarker of HCV\u2011associated hepatocellular carcinoma","volume":"18","author":"Oura","year":"2019","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib90","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5009\/gnl16560","article-title":"Serum MicroRNA levels as a noninvasive diagnostic biomarker for the early diagnosis of hepatitis B virus-related liver fibrosis","volume":"11","author":"Bao","year":"2017","journal-title":"Gut Liver"},{"issue":"9","key":"10.1016\/j.prp.2023.154375_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137706","article-title":"Serum microRNAs as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma in Egyptian patients","volume":"10","author":"Motawi","year":"2015","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.prp.2023.154375_bib92","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/jvh.12696","article-title":"Serum micro RNA s as predictors for liver fibrosis staging in hepatitis C virus\u2010associated chronic liver disease patients","volume":"24","author":"Shaker","year":"2017","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.prp.2023.154375_bib93","article-title":"Study of serum microRNA19a and microRNA223 as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma","volume":"15","author":"Elmougy","year":"2019","journal-title":"Gene Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156652412798376170","article-title":"miR221\/222 in cancer: their role in tumor progression and response to therapy","volume":"12","author":"Garofalo","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib95","doi-asserted-by":"crossref","first-page":"34935","DOI":"10.1038\/srep34935","article-title":"MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C","volume":"6","author":"Appourchaux","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib96","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/jcm5030038","article-title":"Hepatic stellate cells and microRNAs in pathogenesis of liver fibrosis","volume":"5","author":"Kitano","year":"2016","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib97","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/liv.14112","article-title":"Activation of the oncogenic miR\u201021\u20135p promotes HCV replication and steatosis induced by the viral core 3a protein","volume":"39","author":"Cl\u00e9ment","year":"2019","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib98","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1139\/bcb-2014-0095","article-title":"The role of miR-29 in pulmonary fibrosis","volume":"93","author":"Cushing","year":"2015","journal-title":"Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1152\/physiolgenomics.00141.2011","article-title":"The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury","volume":"44","author":"Kriegel","year":"2012","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.prp.2023.154375_bib100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11481-014-9577-6","article-title":"Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs","volume":"10","author":"Zhou","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"15","key":"10.1016\/j.prp.2023.154375_bib101","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1039\/C7RA12815K","article-title":"MiR-29c inhibits HCV replication via activation of type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells","volume":"8","author":"Wang","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.prp.2023.154375_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155076","article-title":"Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections","volume":"131","author":"Ma","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.prp.2023.154375_bib103","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3389\/fonc.2020.01271","article-title":"Dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma: potential as biomarkers and therapeutic targets","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Oncol."},{"issue":"51","key":"10.1016\/j.prp.2023.154375_bib104","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214911119","article-title":"PLK1-ELAVL1\/HuR-miR-122 signaling facilitates hepatitis C virus proliferation","volume":"119","author":"Seo","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib105","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.33881","article-title":"The liver MicroRNA expression profiles associated with chronic hepatitis C virus (HCV) genotype-4 infection: a preliminary study","volume":"16","author":"El-Guendy","year":"2016","journal-title":"Hepat. Mon."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib106","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/CBM-181970","article-title":"Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma","volume":"26","author":"Li","year":"2019","journal-title":"Cancer Biomark."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib107","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000218166","article-title":"Decreased expression of microRNA-143 and-145 in human gastric cancers","volume":"77","author":"Takagi","year":"2009","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib108","first-page":"6115","article-title":"Expression of the microRNA-143\/145 cluster is decreased in hepatitis B virus-associated hepatocellular carcinoma and may serve as a biomarker for tumorigenesis in patients with chronic hepatitis B","volume":"15","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib109","doi-asserted-by":"crossref","first-page":"34157","DOI":"10.1038\/srep34157","article-title":"Potentials of the elevated circulating miR-185 level as a biomarker for early diagnosis of HBV-related liver fibrosis","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.prp.2023.154375_bib110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nchembio.1940","article-title":"MicroRNAs regulate the immunometabolic response to viral infection in the liver","volume":"11","author":"Singaravelu","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"15","key":"10.1016\/j.prp.2023.154375_bib111","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.3748\/wjg.v21.i15.4517","article-title":"MicroRNA-185-5p mediates regulation of SREBP2 expression by hepatitis C virus core protein","volume":"21","author":"Li","year":"2015","journal-title":"World J. Gastroenterol. WJG"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib112","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41467-017-01954-x","article-title":"Cellular microRNA networks regulate host dependency of hepatitis C virus infection","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib113","first-page":"1919","article-title":"Plasma microRNA: a novel non\u2011invasive biomarker for HBV\u2011associated liver fibrosis staging","volume":"17","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib114","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/cancers13030514","article-title":"MicroRNAs in the pathogenesis of hepatocellular carcinoma: A review","volume":"13","author":"Morishita","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154375_bib116","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target. Oncol."},{"issue":"17","key":"10.1016\/j.prp.2023.154375_bib117","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4161\/cc.7.17.6597","article-title":"Mechanisms of microRNA deregulation in human cancer","volume":"7","author":"Deng","year":"2008","journal-title":"Cell Cycle"},{"issue":"19","key":"10.1016\/j.prp.2023.154375_bib118","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.7150\/jca.26350","article-title":"The role of MicroRNAs in hepatocellular carcinoma","volume":"9","author":"Xu","year":"2018","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib119","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/biom12050645","article-title":"Hepatocellular carcinoma: the role of MicroRNAs","volume":"12","author":"Khare","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2023.154375_bib120","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327924","article-title":"MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression","author":"Fu","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.prp.2023.154375_bib121","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00432-017-2480-9","article-title":"All-treatment array of hepatocellular carcinoma from initial diagnosis to death: observation of cumulative treatments","volume":"143","author":"Moon","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154375_bib122","first-page":"1","article-title":"Khoei, MicroRNA-452: a double-edged sword in multiple human cancers","author":"Karimi Dermani","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"13","key":"10.1016\/j.prp.2023.154375_bib123","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or tumor suppressor? The duplicity of microRNAs in cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2023.154375_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2022.08.036","article-title":"A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cells","volume":"30","author":"Tian","year":"2022","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3892\/br.2013.142","article-title":"Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma","volume":"1","author":"Lao","year":"2013","journal-title":"Biomed. Rep."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib126","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bbrc.2017.03.110","article-title":"miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1","volume":"486","author":"Mahati","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib127","first-page":"3261","article-title":"miR\u201129a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3","volume":"40","author":"Liang","year":"2018","journal-title":"Oncol. Rep."},{"issue":"49","key":"10.1016\/j.prp.2023.154375_bib128","doi-asserted-by":"crossref","first-page":"86592","DOI":"10.18632\/oncotarget.21246","article-title":"miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154375_bib129","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/156646","article-title":"miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT","author":"Li","year":"2022","journal-title":"Adv. Clin. Exp. Med. Off. Organ Wroclaw Med. Univ."},{"key":"10.1016\/j.prp.2023.154375_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.593245","article-title":"Malignancy and IFITM3: friend or foe?","volume":"10","author":"Rajapaksa","year":"2020","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cdd.2009.56","article-title":"The miR-34 family in cancer and apoptosis","volume":"17","author":"Hermeking","year":"2010","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.prp.2023.154375_bib132","first-page":"12728","article-title":"miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS","volume":"8","author":"Song","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2023.154375_bib133","first-page":"6046","article-title":"Hepatocellular carcinoma progression is protected by miRNA-34c-5p by regulating FAM83A","volume":"24","author":"Yu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib134","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbrc.2017.01.023","article-title":"Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells","volume":"483","author":"Wu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2023.154375_bib135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00432-016-2280-7","article-title":"MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression","volume":"143","author":"Xiao","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154375_bib136","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.biopha.2016.11.053","article-title":"miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt\/\u03b2-catenin signaling pathway","volume":"85","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154375_bib137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biochi.2018.04.016","article-title":"MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10","volume":"150","author":"Li","year":"2018","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib138","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.ygeno.2020.03.022","article-title":"Effect of scopoletin on phagocytic activity of U937-derived human macrophages: Insights from transcriptomic analysis","volume":"112","author":"Alkorashy","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.prp.2023.154375_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102077","article-title":"Clinical application study on miR-98-5p as a prognostic biomarker in hepatocellular carcinoma","author":"Ji","year":"2023","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"8","key":"10.1016\/j.prp.2023.154375_bib140","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s10620-016-4156-8","article-title":"Oncomirs miRNA-221\/222 and tumor suppressors miRNA-199a\/195 are crucial miRNAs in liver cancer: a systematic analysis","volume":"61","author":"Li","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.prp.2023.154375_bib141","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9950749","article-title":"miR-101-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting EZH2","author":"Dong","year":"2021","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.prp.2023.154375_bib142","first-page":"25","article-title":"miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy","author":"Normann","year":"2022","journal-title":"Breast Cancer.: Targets Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib143","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7150\/thno.33482","article-title":"Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"05","key":"10.1016\/j.prp.2023.154375_bib144","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2217\/pme-2021-0024","article-title":"The role of miR-101 in esophageal and gastric cancer","volume":"18","author":"Syllaios","year":"2021","journal-title":"Pers. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004873","article-title":"Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets","volume":"11","author":"Zheng","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.prp.2023.154375_bib146","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1326463","article-title":"Identification of circulating exosomal mir-101 and mir-125b panel act as a potential biomarker for hepatocellular carcinoma","author":"Sun","year":"2021","journal-title":"Int. J. Genom."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib147","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ijms19010261","article-title":"The role of miRNAs in the pathophysiology of liver diseases and toxicity","volume":"19","author":"Schueller","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib148","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/hepr.12606","article-title":"Dysregulated miRNA in progression of hepatocellular carcinoma: a systematic review","volume":"46","author":"Mizuguchi","year":"2016","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021039662","article-title":"LncRNA DSCAM-AS1 negatively interacts with miR-124 to promote hepatocellular carcinoma proliferation","volume":"32","author":"Wang","year":"2022","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112162","article-title":"miR-124 regulates liver cancer stem cells expansion and sorafenib resistance","volume":"394","author":"Feng","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib151","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41419-021-04491-0","article-title":"MiRNA-124-3p. 1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1","volume":"13","author":"Dong","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib152","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yexcr.2016.03.027","article-title":"MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1","volume":"343","author":"Tian","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"23","key":"10.1016\/j.prp.2023.154375_bib153","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1080\/15384101.2020.1843813","article-title":"The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy","volume":"19","author":"Karbasforooshan","year":"2020","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-021-01343-5","article-title":"Epigenetic silencing of miR-144\/451a cluster contributes to HCC progression via paracrine HGF\/MIF-mediated TAM remodeling","volume":"20","author":"Zhao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2023.154375_bib155","doi-asserted-by":"crossref","first-page":"16861","DOI":"10.1002\/jcp.28368","article-title":"miR\u2010193: a new weapon against cancer","volume":"234","author":"Khordadmehr","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2023.154375_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-12-162","article-title":"Petro, Effects of miR-193a and sorafenib on hepatocellular carcinoma cells","volume":"12","author":"Salvi","year":"2013","journal-title":"Mol. Cancer"},{"issue":"15","key":"10.1016\/j.prp.2023.154375_bib157","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1016\/j.ejca.2010.06.127","article-title":"MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells","volume":"46","author":"Xu","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib158","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/abbs\/gmx017","article-title":"MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1","volume":"49","author":"Wang","year":"2017","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib159","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jhep.2020.07.039","article-title":"MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma","volume":"74","author":"Komoll","year":"2021","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.prp.2023.154375_bib160","first-page":"5149","article-title":"MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2","volume":"23","author":"Gao","year":"2019","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"19","key":"10.1016\/j.prp.2023.154375_bib161","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.3390\/cancers13194983","article-title":"Mir-21 suppression promotes mouse hepatocarcinogenesis","volume":"13","author":"Correia de Sousa","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib162","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2013.05.007","article-title":"MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT\/ERK pathways","volume":"337","author":"Bao","year":"2013","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib163","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib164","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ddr.21257","article-title":"The role of miR\u201021 in cancer","volume":"76","author":"Pfeffer","year":"2015","journal-title":"Drug Dev. Res."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib165","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154375_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.642030","article-title":"MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7\/YAP1 Regulation","volume":"11","author":"Hong","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib167","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2011.08.008","article-title":"MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma","volume":"56","author":"Liu","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2023.154375_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-12-111","article-title":"miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154375_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-016-0328-z","article-title":"miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1","volume":"16","author":"Zeng","year":"2016","journal-title":"Cancer Cell Int."},{"issue":"27","key":"10.1016\/j.prp.2023.154375_bib170","doi-asserted-by":"crossref","first-page":"42566","DOI":"10.18632\/oncotarget.9934","article-title":"Down-regulation of Kr\u00fcppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-\u03b21","volume":"7","author":"Yao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154375_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3053-7","article-title":"High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection","volume":"17","author":"von Felden","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154375_bib172","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.6946.1","article-title":"Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances","volume":"5","author":"Dhanasekaran","year":"2016","journal-title":"F1000Research"},{"issue":"12","key":"10.1016\/j.prp.2023.154375_bib173","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/ijc.31595","article-title":"HBV suppresses ZHX2 expression to promote proliferation of HCC through miR\u2010155 activation","volume":"143","author":"Song","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib174","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/ddr493","article-title":"A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing","volume":"21","author":"Solda","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.prp.2023.154375_bib175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015797","article-title":"Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a","volume":"5","author":"Lin","year":"2010","journal-title":"PloS One"},{"issue":"35","key":"10.1016\/j.prp.2023.154375_bib176","doi-asserted-by":"crossref","first-page":"23204","DOI":"10.1074\/jbc.M109.031427","article-title":"Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells","volume":"284","author":"Guttilla","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib177","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"9","key":"10.1016\/j.prp.2023.154375_bib178","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.prp.2023.154375_bib179","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"10","key":"10.1016\/j.prp.2023.154375_bib180","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib181","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/14756366.2021.2015342","article-title":"1, 3, 4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies","volume":"37","author":"Hagras","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"46","key":"10.1016\/j.prp.2023.154375_bib182","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.prp.2023.154375_bib183","doi-asserted-by":"crossref","unstructured":"A. Garc\u00eda-Pardo, J. Redondo-Mu\u00f1oz, Regulation and function of angiogenic factors in chronic lymphocytic leukemia, (2021).","DOI":"10.20517\/2394-4722.2021.103"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib184","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-018-0766-4","article-title":"New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.prp.2023.154375_bib186","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: Antibacterial, antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.prp.2023.154375_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"key":"10.1016\/j.prp.2023.154375_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154375_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118518","article-title":"Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein","volume":"262","author":"El-Mahdy","year":"2020","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib190","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.123","article-title":"MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2","volume":"8","author":"Ghosh","year":"2017","journal-title":"Cell death Dis."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib191","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/mc.22286","article-title":"OncomiR miR\u201096 and miR\u2010182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma","volume":"55","author":"Wang","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib192","first-page":"96","article-title":"MiR-133a and MiR-155 as potential minimally invasive biomarkers in breast cancer","volume":"7","author":"Elshimy","year":"2017","journal-title":"Cancer Biol."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib193","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3892\/or.2014.3306","article-title":"Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties","volume":"32","author":"He","year":"2014","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.prp.2023.154375_bib194","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bulcan.2018.07.013","article-title":"Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1","volume":"105","author":"Jiang","year":"2018","journal-title":"Bull. du Cancer"},{"issue":"8","key":"10.1016\/j.prp.2023.154375_bib195","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1111\/jcmm.14361","article-title":"Micro RNA\u2010301b\u20103p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4","volume":"23","author":"Guo","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2023.154375_bib196","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11010-013-1940-z","article-title":"MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B","volume":"389","author":"Zheng","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.prp.2023.154375_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"issue":"19","key":"10.1016\/j.prp.2023.154375_bib198","doi-asserted-by":"crossref","first-page":"28000","DOI":"10.18632\/oncotarget.8584","article-title":"MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt\/\u03b2-catenin signaling pathway","volume":"7","author":"Zheng","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib199","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2559.2010.03686.x","article-title":"Deregulation of miR\u2010519a, 153, and 485\u20135p and its clinicopathological relevance in ovarian epithelial tumours","volume":"57","author":"Kim","year":"2010","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib200","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/path.4363","article-title":"MicroRNA\u2010519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour\u2010suppressor genes in ER+ breast cancer","volume":"233","author":"Ward","year":"2014","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib201","first-page":"1","article-title":"Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation","volume":"10","author":"Zhou","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib202","first-page":"1","article-title":"MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-\u03baB signaling pathway","volume":"6","author":"Tan","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"El Andaloussi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-015-0148-3","article-title":"Signaling by exosomal microRNAs in cancer","volume":"34","author":"Falcone","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154375_bib205","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s13277-014-2807-y","article-title":"Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer","volume":"36","author":"Li","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2023.154375_bib206","article-title":"Exosomes in chronic liver disease","author":"Mohan","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"32","key":"10.1016\/j.prp.2023.154375_bib207","doi-asserted-by":"crossref","first-page":"13109","DOI":"10.1073\/pnas.1221899110","article-title":"Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7. 5 cells","volume":"110","author":"Ramakrishnaiah","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3\u20134","key":"10.1016\/j.prp.2023.154375_bib208","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbrc.2014.10.146","article-title":"Exosome-associated hepatitis C virus in cell cultures and patient plasma","volume":"455","author":"Liu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib209","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ymthe.2017.03.031","article-title":"Exosome-mediated miR-155 transfer from smooth muscle cells to endothelial cells induces endothelial injury and promotes atherosclerosis","volume":"25","author":"Zheng","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.prp.2023.154375_bib210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fimmu.2016.00335","article-title":"Extracellular vesicles including exosomes regulate innate immune responses to hepatitis B virus infection","volume":"7","author":"Kouwaki","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2023.154375_bib211","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virusres.2017.08.009","article-title":"The HBx gene of hepatitis B virus can influence hepatic microenvironment via exosomes by transferring its mRNA and protein","volume":"240","author":"Kapoor","year":"2017","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib212","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cmi.2016.24","article-title":"Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction","volume":"14","author":"Yang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib213","first-page":"323","article-title":"Exosomes derived from HBV\u2011associated liver cancer promote chemoresistance by upregulating chaperone\u2011mediated autophagy","volume":"17","author":"Liu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"24","key":"10.1016\/j.prp.2023.154375_bib214","doi-asserted-by":"crossref","first-page":"e01578","DOI":"10.1128\/JVI.01578-18","article-title":"Exosomes exploit the virus entry machinery and pathway to transmit alpha interferon-induced antiviral activity","volume":"92","author":"Yao","year":"2018","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib215","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1074\/mcp.M116.063503","article-title":"Label-free proteomic analysis of exosomes derived from inducible hepatitis B virus-replicating HepAD38 cell line","volume":"16","author":"Jia","year":"2017","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.prp.2023.154375_bib216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2018.09.029","article-title":"Exosomes as adjuvants for the recombinant hepatitis B antigen: first report","volume":"133","author":"Jesus","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.prp.2023.154375_bib217","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jvh.12995","article-title":"Extracellular vesicles from hepatitis B patients serve as reservoir of hepatitis B virus DNA","volume":"26","author":"Sukriti","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib218","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbcan.2014.04.005","article-title":"A comprehensive overview of exosomes as drug delivery vehicles\u2014endogenous nanocarriers for targeted cancer therapy","volume":"1846","author":"Johnsen","year":"2014","journal-title":"Biochim. Et. Biophys. Acta BBA Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154375_bib219","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12033-018-0114-3","article-title":"DNA vectors generating engineered exosomes potential CTL vaccine candidates against AIDS, hepatitis B, and tumors","volume":"60","author":"Ferrantelli","year":"2018","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.prp.2023.154375_bib220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trivac.2016.05.001","article-title":"Engineered exosomes boost the HCV NS3-specific CD8+ T lymphocyte immunity in humans","volume":"5","author":"Anticoli","year":"2016","journal-title":"Trials Vaccinol."},{"issue":"9","key":"10.1016\/j.prp.2023.154375_bib221","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.5966\/sctm.2015-0348","article-title":"Exosomal microRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infection","volume":"5","author":"Qian","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.prp.2023.154375_bib222","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12072-020-10096-0","article-title":"Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism","volume":"14","author":"Li","year":"2020","journal-title":"Hepatol. Int."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104597","article-title":"M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model","volume":"25","author":"Wan","year":"2022","journal-title":"Iscience"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis","volume":"13","author":"Momen-Heravi","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2023.154375_bib225","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11481-019-09848-z","article-title":"Extracellular vesicles: intercellular mediators in alcohol-induced pathologies","volume":"15","author":"Rahman","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.prp.2023.154375_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109034","article-title":"miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN\/PDGFR-\u03b2","volume":"110","author":"Chen","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.prp.2023.154375_bib227","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/cells11101715","article-title":"Extracellular vesicular transmission of miR-423-5p from HepG2 cells inhibits the differentiation of hepatic stellate cells","volume":"11","author":"Safran","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.prp.2023.154375_bib228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0706-8","article-title":"Role of exosomal proteins in cancer diagnosis","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib229","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/cancers15010205","article-title":"Serum-exosome-derived miRNAs serve as promising biomarkers for HCC diagnosis","volume":"15","author":"Rui","year":"2023","journal-title":"Cancers"},{"issue":"45","key":"10.1016\/j.prp.2023.154375_bib230","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.3748\/wjg.15.5633","article-title":"Emerging role of microRNAs in liver diseases","volume":"15","author":"Bala","year":"2009","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib231","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/jhg.2016.53","article-title":"MicroRNAs and liver disease","volume":"62","author":"Otsuka","year":"2017","journal-title":"J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.prp.2023.154375_bib232","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib233","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"100","key":"10.1016\/j.prp.2023.154375_bib234","doi-asserted-by":"crossref","first-page":"ra81","DOI":"10.1126\/scisignal.2000610","article-title":"Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection","volume":"2","author":"Zernecke","year":"2009","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib235","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib236","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008308","article-title":"Various miRNAs compensate the role of miR-122 on HCV replication","volume":"16","author":"Ono","year":"2020","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.prp.2023.154375_bib237","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib238","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1038\/s41598-020-65213-8","article-title":"Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma","volume":"10","author":"Trung","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib239","doi-asserted-by":"crossref","DOI":"10.1063\/5.0085078","article-title":"Microfluidic system for near-patient extraction and detection of miR-122 microRNA biomarker for drug-induced liver injury diagnostics","volume":"16","author":"Kersaudy-Kerhoas","year":"2022","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.prp.2023.154375_bib240","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.15661","article-title":"Analysis of serum microRNA\u2010122 in a randomised controlled trial of N\u2010acetylcysteine for treatment of anti\u2010tuberculosis drug\u2010induced liver injury","author":"Moosa","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib241","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/cells9041005","article-title":"Noninvasive diagnosis of NAFLD and NASH","volume":"9","author":"Piazzolla","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib242","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/1354750X.2021.1874051","article-title":"Chronic exposure to ethanol alters the expression of miR-155, miR-122 and miR-217 in alcoholic liver disease in an adult zebrafish model","volume":"26","author":"Pasqualotto","year":"2021","journal-title":"Biomarkers"},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2021.12353","article-title":"Functional role of miR\u2011155 in physiological and pathological processes of liver injury","volume":"24","author":"Feng","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib244","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2478\/jtim-2020-0006","article-title":"MiR-155 and MiR-665 role as potential non-invasive biomarkers for hepatocellular carcinoma in Egyptian patients with chronic hepatitis C virus infection","volume":"8","author":"Mohamed","year":"2020","journal-title":"J. Transl. Intern. Med."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib245","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.25849","article-title":"Hepatitis C virus\u2010induced up\u2010regulation of microRNA\u2010155 promotes hepatocarcinogenesis by activating Wnt signaling","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2023.154375_bib246","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00203-021-02233-6","article-title":"Expression profiling of miRNA-196a biomarker in na\u00efve hepatitis C virus-infected and Sofosbuvir plus Daclatasvir-treated patients","volume":"203","author":"Hussain","year":"2021","journal-title":"Arch. Microbiol."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib247","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23025","article-title":"NF\u2010\u03baB\u2010upregulated miR\u2010155\u20135p promotes hepatocyte mitochondrial dysfunction to accelerate the development of nonalcoholic fatty liver disease through downregulation of STC1","volume":"36","author":"Shen","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.prp.2023.154375_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113725","article-title":"MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation","volume":"171","author":"Kugler","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-020-01334-8","article-title":"Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"20","author":"Xin","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib250","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.21608\/ejhm.2022.268100","article-title":"Associations of MicroRNA-34a expression profile; serum levels of vascular endothelial growth factor and disease progression in Hepatitis C patients","volume":"89","author":"Matta","year":"2022","journal-title":"Egypt. J. Hosp. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-00638-3","article-title":"MiR-571 affects the development and progression of liver fibrosis by regulating the Notch3 pathway","volume":"11","author":"Cong","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib252","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1247\/csf.17005","article-title":"MiR-29a and miR-652 attenuate liver fibrosis by inhibiting the differentiation of CD4+ T cells","volume":"42","author":"Xuan","year":"2017","journal-title":"Cell Struct. Funct."},{"issue":"5","key":"10.1016\/j.prp.2023.154375_bib253","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.12669\/pjms.35.5.685","article-title":"MicroRNA-21 as a diagnostic marker for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"35","author":"Qu","year":"2019","journal-title":"Pak. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib254","first-page":"219","article-title":"Circulating miRNA-199a and miRNA-122 levels as potential diagnostic and prognostic biomarkers for hepatocellular carcinoma","volume":"50","author":"Wu","year":"2020","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/jpm11030219","article-title":"New insights into the role of miR-29a in hepatocellular carcinoma: Implications in mechanisms and theragnostics","volume":"11","author":"Yang","year":"2021","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib256","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15037316","article-title":"Low miR-29c expression is a prognostic marker in hepatocellular carcinoma","volume":"15","author":"Dong","year":"2016","journal-title":"Genet Mol. Res"},{"key":"10.1016\/j.prp.2023.154375_bib257","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biopha.2018.07.151","article-title":"MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-\u03b2\/Smad3 signaling pathway","volume":"107","author":"Sun","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib258","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3892\/etm.2017.4348","article-title":"MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6","volume":"13","author":"Xue","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib259","first-page":"104","article-title":"The role of serum microRNA-192 for early diagnosis of hepatitis C virus-related hepatocellular carcinoma","volume":"35","author":"Abd-Elatty","year":"2022","journal-title":"Menou Med. J."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib260","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1470-2045(15)00048-0","article-title":"A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib261","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/hep.28660","article-title":"Circulating let\u20107 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C","volume":"64","author":"Matsuura","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib262","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte\u2010derived exosomal microRNA 192\u20135p activates macrophages through rictor\/Akt\/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib263","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/hep.30766","article-title":"Dysregulated autophagy and lysosome function are linked to exosome production by micro\u2010RNA 155 in alcoholic liver disease","volume":"70","author":"Babuta","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib264","first-page":"137","article-title":"Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma","volume":"23","author":"Cheng","year":"2019","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib265","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jhep.2011.11.026","article-title":"Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma","volume":"56","author":"Borel","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2023.154375_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113327","article-title":"Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma","volume":"153","author":"Sheng","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154375_bib267","series-title":"Seminars in Cancer Biology","first-page":"136","article-title":"Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma","author":"Cao","year":"2021"},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib268","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gutjnl-2014-308969","article-title":"Antitumour activity of an inhibitor of miR-34a in liver cancer with \u03b2-catenin-mutations","volume":"65","author":"Gougelet","year":"2016","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.prp.2023.154375_bib269","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242179","article-title":"MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7","volume":"15","author":"Zhao","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib270","doi-asserted-by":"crossref","DOI":"10.5114\/aoms.2019.91351","article-title":"MiR-93 suppresses cell proliferation and invasion by targeting ZNF322 in human hepatocellular carcinoma","volume":"19","author":"Zhang","year":"2023","journal-title":"Arch. Med. Sci."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib271","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbrc.2013.12.095","article-title":"MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells","volume":"443","author":"Zhang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib272","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.3892\/ol.2017.6573","article-title":"Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA\u20117 in human hepatocellular carcinoma cells","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2023.154375_bib273","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105442","article-title":"Exosomes-transmitted miR-7 reverses gefitinib resistance by targeting YAP in non-small-cell lung cancer","volume":"165","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.prp.2023.154375_bib274","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fonc.2019.00175","article-title":"Schistosoma japonicum MiRNA-7-5p inhibits the growth and migration of hepatoma cells via cross-species regulation of S-phase kinase-associated protein 2","volume":"9","author":"Hu","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-021-04972-3","article-title":"MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-\u03b2\/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7","volume":"14","author":"Zhou","year":"2021","journal-title":"Parasites Vectors"},{"issue":"6","key":"10.1016\/j.prp.2023.154375_bib276","first-page":"683","article-title":"The protective effect of bone marrow-derived mesenchymal stem cells in liver ischemia\/reperfusion injury via down-regulation of miR-370","volume":"22","author":"Zare","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.prp.2023.154375_bib277","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12011-018-1425-8","article-title":"The effect of zinc sulfate on miR-122, miR-34a, Atioxidants, biochemical and Histopathological parameters following hepatic ischemia\/reperfusion injury in rats","volume":"188","author":"Mard","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154375_bib278","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/liv.12441","article-title":"A role of microRNA\u2010370 in hepatic ischaemia\u2010reperfusion injury by targeting transforming growth factor\u2010\u03b2 receptor II","volume":"35","author":"Li","year":"2015","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.prp.2023.154375_bib279","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hep.29144","article-title":"MicroRNA 181b\u20103p and its target importin \u03b15 regulate toll\u2010like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol","volume":"66","author":"Saikia","year":"2017","journal-title":"Hepatology"},{"issue":"5962","key":"10.1016\/j.prp.2023.154375_bib280","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.prp.2023.154375_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.03.003","article-title":"miRNA-338-3p\/CAMK II\u03b1 signaling pathway prevents acetaminophen-induced acute liver inflammation in vivo","volume":"21","author":"Zhang","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"8","key":"10.1016\/j.prp.2023.154375_bib282","first-page":"844","article-title":"Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish","volume":"1863","author":"Lai","year":"2018","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.prp.2023.154375_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120925","article-title":"MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes","volume":"308","author":"Wang","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154375_bib284","doi-asserted-by":"crossref","first-page":"10235","DOI":"10.1007\/s13277-016-4836-1","article-title":"MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib285","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/hep.29478","article-title":"A microRNA\u20107\/growth arrest specific 6\/TYRO3 axis regulates the growth and invasiveness of sorafenib\u2010resistant cells in human hepatocellular carcinoma","volume":"67","author":"Kabir","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.prp.2023.154375_bib286","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1038\/ncomms10993","article-title":"MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression","volume":"7","author":"Hyun","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.154375_bib287","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00109-015-1282-2","article-title":"MiR-26a enhances autophagy to protect against ethanol-induced acute liver injury","volume":"93","author":"Han","year":"2015","journal-title":"J. Mol. Med."},{"issue":"7","key":"10.1016\/j.prp.2023.154375_bib288","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.196","article-title":"Activation of the SIRT1\/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease","volume":"6","author":"Shan","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2023.154375_bib289","article-title":"Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progression","author":"Fernandez Tussy","year":"2023","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.prp.2023.154375_bib290","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00335-022-09945-0","article-title":"RMRP inhibition prevents NAFLD progression in rats via regulating miR-206\/PTPN1 axis","volume":"33","author":"Yin","year":"2022","journal-title":"Mamm. Genome"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:58:47Z","timestamp":1759733927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823000754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":290,"alternative-id":["S0344033823000754"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154375","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of miRNAs in liver diseases: Potential therapeutic and clinical applications","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154375"}}